We observed that oxaliplatin could significantly inhibit proliferation of these two CRC cells (Fig. 7B-C), but only UCA1, MIR22HG, MIR17HG showed significantly different after oxaliplatin treatment in both cell lines (Fig. 7D). Here, MIR22HG is linked to colorectal carcinoma.